Investment Pitches

Pitch Summary:
MGM Resorts International (MGM) was a material contributor to portfolio gains after delivering strong quarterly results. The company benefited from solid demand across its Las Vegas properties, while its Macau operations continued to recover. Management commentary indicated confidence in margin stability and ongoing leisure demand strength. MGM’s diversified asset base and improving international trends provided further support to performance during the period.

BSD Analysis:
From a third-party perspective, MGM combines resilient Las Vegas fundamentals with a still-recovering Macau segment, creating a multi-year earnings-growth opportunity. Strong leisure and convention demand, disciplined cost control, and improving international visitation support margin stability. The company’s asset-light strategy and share-repurchase commitment enhance capital-return potential. Key risks include macro sensitivity and regulatory dynamics in Macau, but overall positioning remains favorable.

Pitch Summary:
While stock selection drove the strong Q2 performance, Microsoft (MSFT) was one of three contributors to the quarter from our core long equity holdings. Microsoft continues to demonstrate durable competitive advantages across cloud services, enterprise software, and AI adoption. Growth in Azure and increasing demand for AI-enabled tools helped support strong top-line momentum during the period. The company’s scale, diversified revenue base, and ability to monetize AI-driven workloads position Microsoft for attractive long-term earnings growth despite broader macro uncertainty.

BSD Analysis:
Analysts view Microsoft as the premier scaled AI and cloud platform, underpinned by accelerating Azure growth and expanding Copilot monetization. Its dominant enterprise ecosystem and recurring-revenue model support margin durability and strong free-cash-flow compounding. With a robust balance sheet and continued investment in AI infrastructure, Microsoft maintains one of the strongest long-duration growth profiles in large-cap technology.

Pitch Summary:
Vistra Corp. (VST) was the largest contributor to quarterly performance during the period, driven by a growing understanding of the magnitude of data center power requirements. Looking ahead, we expect incremental data center power demand to continue to support new capacity additions, while power markets overall remain tight given existing industry dynamics and relatively few projects in the pipeline. The company’s strong market position, coupled with exposure to favorable trends in data center growth, leaves VST well positioned to benefit from these structural tailwinds.

BSD Analysis:
From a third-party viewpoint, Vistra is a direct beneficiary of accelerating U.S. data-center load growth, which is tightening reserve margins and improving forward pricing across multiple power markets. Its diversified generation fleet and retail footprint provide stable cash flows, while incremental capacity additions should enhance earnings visibility. With limited new build supply on the horizon, Vistra’s assets may command higher implied valuations, supporting further free-cash-flow growth and capital returns. Key risks include regulatory shifts and commodity volatility, but structural demand appears favorable.

Pitch Summary:
We started a new position in Applied Materials (AMAT), a global supplier of equipment used in the fabrication of semiconductors. Surging demand for advanced chips that fuel Artificial Intelligence (AI), and high-performance computing is driving a significant investment in semiconductor manufacturing equipment. AMAT is well positioned to capitalize on this trend. The company has a track record of strong performance, consistently generating significant cash flow from operations, allowing it to invest in R&D and return value to shareholders through buybacks and dividends. This is an example of a company that we had previously done the work on hoping for an opportunity to add it to the LCV portfolio on price weakness. We started our position after the April 2nd reciprocal tariff announcements caused a sharp, short-lived market pullback.

BSD Analysis:
Applied Materials benefits from a multi-year wafer fabrication equipment upcycle driven by AI, high-performance computing, and leading-edge node transitions. AMAT trades at a reasonable forward P/E relative to peers despite superior cash generation and strong operating leverage. Its consistent R&D investment and dominant market share in deposition and etch tools reinforce its competitive moat. Capital returns via dividends and robust buybacks enhance total shareholder yield. Key catalysts include expanded foundry/logic capex, CHIPS Act–supported U.S. fab builds, and rising demand for advanced process equipment.

Pitch Summary:
Nvidia reported first quarter results that were extremely solid. The company took a write-down on China-specific datacenter products and flushed out any future China contributions from their guidance, following the new export restrictions introduced in April. Demand commentary ex China was extremely encouraging—Nvidia is outgrowing expectations despite supply constraints and outgrowing competing ASIC products by a large margin. We have been underweight Nvidia relative to the benchmark, which was up 46% in the quarter, given our short-to-medium-term concerns that the feverish AI datacenter build may be resulting in overcapacity, which has not come to bear.

BSD Analysis:
NVIDIA is no longer just a semiconductor company; it’s the control plane for the global AI build-out. Its GPUs, networking, and software stack have become the default infrastructure for training and running large-scale AI models. CUDA remains a powerful moat, locking developers into an ecosystem that compounds with every new application built. While custom silicon and competitors are emerging, they mostly address overflow demand rather than displacing NVIDIA at the core. The next leg of growth is inference, which broadens demand beyond hyperscalers into enterprises and edge deployments. Valuation is elevated, but that reflects NVIDIA’s position as a bottleneck supplier in an AI arms race. As long as compute intensity keeps rising, NVIDIA’s earnings power remains structurally advantaged.

Pitch Summary:
KE Holdings reported a solid 1Q25. The stock was impacted by tariff announcements and their potential secondary impact on the Chinese economy and real estate prices. The company’s guidance for 2Q25 came in below consensus. Management signaled for continuous cost optimization in the future. We remain positive on the stock over the long term.

BSD Analysis:
KE Holdings (Beike) is the dominant, high-growth digital real estate platform in China whose stock is a conviction bet on the eventual stabilization and professionalization of the Chinese housing market. The core moat is its A−Ha platform, which provides an indispensable, comprehensive digital ecosystem for agents, buyers, and sellers across transactions and housing services. This platform creates a powerful network effect that is incredibly difficult to replicate, cementing its market leadership despite short-term macro headwinds. The company's focus on ESG compliance and transparent transactions positions it to benefit from government policy favoring market stability. The stock is a leveraged play on the long-term, structural growth of China's professional real estate market.

Pitch Summary:
Fairfax posted another quarter of solid premium growth and underwriting performance despite significant catastrophe losses related to the Los Angeles wildfires. Fairfax’s ability to absorb such a large catastrophe loss while still generating an underwriting profit is a testament to the insurance operations’ scale and diversification, as well as the experience and skill of its management team. Fairfax grew book value per share 14% y/y and continued to return capital to shareholders via share repurchases.

BSD Analysis:
Fairfax is a unique, deeply discounted insurance and investment holding company whose value is structurally secured by the disciplined, long-term, value-oriented investing of its founder, Prem Watsa. The core thesis is an arbitrage play on the relentless, compounding growth of its Book Value per Share. The company's two engines—Property and Casualty Insurance/Reinsurance and Value-Oriented Investment Management—create an all-weather financial fortress. This approach is designed to produce above-average returns over the long term, with its disciplined underwriting and patient investment strategy being its unassailable moat. Fairfax is a conviction bet on the enduring success of value-based compounding.

Pitch Summary:
Safran reported first quarter revenue that was up 17% y/y, exceeding expectations across all divisions. With Airbus and Boeing continuing to face difficulties increasing production of new aircraft to meet demand, airlines are utilizing their existing fleets at higher rates for longer, underpinning solid engine aftermarket volumes and pricing over the short and medium term. Safran raised its 2025 engine spare part volume guidance and plansto implement a high-single-digit price increase in August.

BSD Analysis:
Safran is a high-quality, indispensable aerospace engine and components pure-play whose stock is a conviction bet on the long-term, high-margin aftermarket services (MRO) supercycle. The core thesis is driven by the company's dominance in providing aero engines, landing gear, and electrical systems for the global commercial fleet. The company maintains an "investment grade" credit rating of A− (stable outlook), reflecting its ability to generate solid free operating cash flow. Its large exposure to the narrow-body aircraft market ensures predictable, high-margin recurring revenue from long-duration service contracts. Safran is a defensive compounder whose financial strength and essential role in the aerospace supply chain secure its long-term profitability.

Pitch Summary:
CME Group is described as the world’s “risk bookmaker,” benefiting from powerful network effects and near-monopoly positions in key futures contracts. The exchange’s vertically integrated execution and clearing model reinforces liquidity and lowers transaction costs, creating a winner-takes-all dynamic. CME is particularly well positioned to benefit from long-term growth in U.S. government debt markets, which should drive sustained increases in interest rate futures trading volumes. Additionally, improved retail brokerage technology and smaller contract sizes are expanding access for a new class of pro-retail traders. Historically, CME has performed exceptionally well during periods of heightened volatility, positioning it as both a structural compounder and a hedge in uncertain markets.

BSD Analysis:
CME Group is an unassailable, high-margin financial exchange oligopolist whose stock is a conviction bet on the structural dominance of its derivatives marketplace. The core moat is its near-monopoly on high-volume futures and options contracts (interest rates, currencies, energy), creating an unbreakable network effect where liquidity attracts liquidity. The financial model is structurally superior, maintaining a colossal pre-tax profit margin of 76.5% in the last quarter. Despite uninspiring revenue growth in the short term, the company’s operating discipline is evident as expenses have consistently grown slower than revenue, driving accelerating earnings growth. CME is a defensive compounder whose fortress balance sheet (low 0.1x debt-to-equity) and essential role in global financial plumbing justify its premium valuation.

Pitch Summary:
GE Aerospace was cited as a key beneficiary of robust aftermarket demand alongside Safran. The managers highlighted structural drivers including aging fleets, delayed aircraft deliveries, and sustained global air traffic growth. Aftermarket backlogs are expanding as service demand outpaces capacity, reinforcing confidence in near-term growth. Industry feedback from the Paris Air Show supported expectations for prolonged strength across engine maintenance and services.

BSD Analysis:
GE Aerospace is now a more focused, higher-quality engine and services company, and that focus is exactly what investors wanted for years. The engine installed base and aftermarket economics are the crown jewels: long-duration service contracts tied to flight hours create powerful recurring revenue. As aircraft utilization normalizes and new deliveries ramp, GE benefits from both volume and higher-margin service mix. Execution risk remains around supply chain constraints and durability issues, but the trend in operational discipline has improved meaningfully. GE’s position on major narrowbody and widebody platforms gives it long-cycle visibility and pricing leverage. This is less about quarter-to-quarter deliveries and more about a compounding service annuity. If the cycle stays constructive, GE Aerospace can grow into a premium-quality industrial multiple.

Pitch Summary:
Safran benefited from continued strength in the aerospace aftermarket, driven by aging fleets, high aircraft utilization, and sustained air traffic growth. Aftermarket demand is consistently outpacing capacity, with engine maintenance wait times stretching from months to years. Insights from the Paris Air Show reinforced expectations for above-average growth to persist near term. This environment strongly favors engine manufacturers like Safran with large installed bases and long-duration service contracts.

BSD Analysis:
Safran is one of the best aerospace compounders because it earns the real money in engines and aftermarket services, not just selling hardware. Flight hours drive recurring service revenue, and the installed base grows over time, creating a compounding annuity-like profile. The company benefits from strong positions in propulsion, aircraft equipment, and defense, giving it both growth and resilience. The key risk is supply-chain execution and production rates—when OEM ramps get messy, timing and margins can wobble. Still, once an engine platform is entrenched, it’s extremely sticky and lasts for decades. Safran’s pricing power and engineering depth make it hard to displace. If global travel holds up, Safran’s cash flow profile can remain structurally strong.

Pitch Summary:
Aerospace was the largest contributor to portfolio performance, supported by insights from meetings at the Paris Air Show. Airbus is benefiting from an improving outlook for original equipment as supply chain constraints gradually ease, enabling delivery acceleration against a large multi-year order backlog. Pricing is highlighted as an underappreciated tailwind, with new aircraft reportedly selling at 30–40% premiums to pre-pandemic levels due to supply-demand imbalance. Management cited significant reductions in missing parts and progress toward peak production levels. These dynamics support confidence in sustained earnings growth into the late 2020s and early 2030s.

BSD Analysis:
Airbus is in an enviable position: commercial aircraft demand is strong, fleet replacement is unavoidable, and supply constraints limit how fast capacity can come online. The duopoly structure with Boeing gives Airbus pricing power and long-cycle visibility that most industrials can’t dream of. The main bottleneck is execution—engines, suppliers, and production ramp stability are the constraints that determine delivery timing and cash flow. Aftermarket and services add a higher-margin layer, though OEM economics still dominate the narrative. Defense and space provide diversification, but commercial remains the big lever. If production ramps cleanly, operating leverage is substantial because fixed costs don’t rise proportionally. Airbus is essentially a long-duration bet on global air travel and disciplined industrial execution.

Pitch Summary:
Mastercard declined alongside Visa as headlines around stablecoin regulation and adoption triggered a market selloff. The managers emphasize that stablecoins offer limited advantages in everyday consumer payments, where Mastercard’s network already provides low costs, rewards, and fraud protection. Merchant and consumer inertia further limits rapid behavioral change. Importantly, Mastercard has announced partnerships in the stablecoin ecosystem, positioning itself to benefit from innovation rather than be displaced. The firm concludes that Mastercard’s competitive position remains robust despite short-term volatility.

BSD Analysis:
Mastercard has the same “global commerce tollbooth” economics as Visa, with strong exposure to cross-border volumes and higher-growth digital flows. The company’s strategy increasingly focuses on being more than a card network—identity, fraud prevention, tokenization, and B2B payments are all higher-value layers. That shift matters because it reduces dependence on any single fee line and strengthens switching costs for customers. Regulatory scrutiny is always present, but Mastercard’s global diversification and services attach provide resilience. The big upside comes when travel and cross-border commerce are healthy, because those flows carry better economics. The risk is mostly valuation sensitivity and any major regulatory hit to pricing. It remains one of the cleanest long-duration compounders in financial infrastructure.

Pitch Summary:
Visa underperformed during the quarter amid investor concerns around the adoption of stablecoins and potential disruption to card networks. The managers argue that stablecoins may offer benefits in cross-border remittances but provide limited value in consumer payments, where card networks already deliver low merchant costs, rewards, and protections. Consumer adoption faces a chicken-and-egg problem, limiting near-term displacement risk. Furthermore, Visa has proactively announced stablecoin partnerships, reflecting that innovation is more likely to be built on top of existing card rails rather than replace them. As a result, the firm believes Visa’s dominant position in the payments ecosystem remains intact.

BSD Analysis:
Visa is effectively a toll collector on global commerce, earning high-margin fees as money moves across its network. The core growth driver is still the long, steady shift from cash to electronic payments, especially in emerging markets. Visa doesn’t take credit risk, which makes the model cleaner than lenders—its business is rails, rules, and security. New flows like B2B payments, cross-border, and real-time connectivity extend the runway beyond consumer card swipes. Regulatory and interchange pressure are ongoing, but Visa has repeatedly adapted while preserving economics through value-added services and network scale. Operating margins and free cash flow are elite, enabling consistent buybacks and compounding per share. It’s a quality financial with tech-like scalability.

Pitch Summary:
The managers remain optimistic on Amazon’s cloud business as a core beneficiary of accelerating AI adoption. Similar to Microsoft, enterprises are increasingly shifting workloads to the cloud to access AI capabilities that require significant computing power. The letter highlights confidence that Amazon can generate attractive returns on its elevated capital investment cycle, drawing on historical precedent from earlier AWS expansion phases. AWS is positioned as a foundational infrastructure layer for AI, with long-term demand visibility supported by secular enterprise migration and data intensity. This dynamic reinforces Amazon’s strategic importance despite ongoing market debate around capex and near-term returns.

BSD Analysis:
Amazon is still two businesses: a retail/logistics machine that trades short-term profits for long-term dominance, and AWS, a high-margin cloud utility powering modern computing. The retail side has improved efficiency meaningfully, and fulfillment optimization is finally translating into better margins without sacrificing customer experience. AWS remains the core profit engine, and AI workloads are creating a new demand wave that can re-accelerate growth. Advertising is an underappreciated third leg—high-margin, data-driven, and increasingly important to brands chasing purchase intent. The risk is that competition in cloud and retail never sleeps, and capex demands remain huge. But Amazon’s scale advantages in logistics, data, and distribution keep compounding. If you want one company exposed to consumer, enterprise, and AI infrastructure, this is the blunt instrument.

Pitch Summary:
Microsoft rallied approximately 32% in Q2 and a further 8% following earnings as Azure cloud growth significantly exceeded expectations. Management highlighted Azure AI revenues growing 175% year over year and a fivefold increase in the number of tokens processed, underscoring accelerating AI-driven demand. Importantly, AI is acting as a catalyst for broader cloud adoption as enterprises migrate workloads to access cloud-native AI tools. While there has been debate around the scale of capital expenditure and returns, the firm draws parallels to Microsoft’s mid-2010s cloud buildout, which ultimately produced a $95 billion revenue business with 25–30% operating margins. The AI business is already operating below peak capital intensity from the prior cloud cycle while generating nearly $14 billion in annualized revenue after just two years.

BSD Analysis:
Microsoft is the default platform for enterprise IT, and the AI wave is turning that platform advantage into a new monetization layer. Azure’s integration with Office, security, and developer tools creates powerful lock-in, making Microsoft one of the most durable “budget line item” vendors in corporate tech. Copilot embeds AI into workflows, which is how AI goes from hype to recurring revenue at scale. The company’s security franchise is also quietly becoming a major growth engine as threats increase and customers consolidate vendors. The main risk is capex intensity—AI is compute-hungry—but Microsoft can fund it with enormous cash flow. Regulation is a permanent background risk for a company this dominant, but Microsoft has a long track record of navigating it. This is the cleanest mega-cap way to own AI, cloud, and enterprise software compounding.

Pitch Summary:
Sanuwave continues on with the theme of rapid growth and an imminent Nasdaq uplisting. In March, SNWV announced its uplisting to the Nasdaq and was added to the Russell 2000 index at the end of June. For the first half of the year, Sanuwave has grown revenue 51%. Even more impressive, this growth was achieved without a national sales presence. Following the first half of the year, the company now has a national sales force along with a key account manager focused on pursuing large accounts that have several hundred locations across the country. Management reaffirmed guidance for the year, which appears to be on the conservative side as it doesn’t include the potential for any new large accounts. Additionally, management indicated that they have been pursuing options to refinance their debt and have received several options with very attractive terms, removing the fear of a potential equity offering. With a large account manager and their first ever targeted outbound marketing campaign I expect Sanuwave to continue to execute. Gross margins should continue to expand beyond the current 78% through manufacturing improvements. Shares continue to represent an attractive investment as the company trades at a discount to similar medical device companies with less attractive growth prospects.

BSD Analysis:
Sanuwave is a micro-cap medtech-style story where the entire investment case typically hinges on clinical validation, commercialization execution, and funding runway. If the technology improves outcomes and reimbursement is achievable, upside can be large because small starting revenue bases scale fast. The downside is dilution risk and long sales cycles—hospitals and clinics don’t adopt new devices quickly without clear economic proof. Investors should watch regulatory status, payer coverage progress, and whether repeat usage is growing, not just headline announcements. Manufacturing, distribution, and clinician training can become hidden execution traps. This is not a “steady compounder” setup; it’s a high-variance adoption and financing story. Position sizing matters more than conviction here.

Pitch Summary:
Solésence (SLSN), formerly Nanophase Technologies (NANX), manufactures zinc oxide, a crucial mineral for sunscreens that protects against both UVA and UVB rays. The company caught my attention during the first half of 2024 as an intriguing investment due to its stock price being under pressure despite its rapid growth and attractive product offering. This was due to manufacturing issues that squeezed profit margins and a lawsuit with a long-term customer. However, management's commentary suggested these problems were likely to be resolved favorably in the near term along with continued rapid growth and a potential uplisting to the Nasdaq. The company resolved the litigation favorably last April and continues to do business with the customer, removing an overhang on the stock price. Revenue for the first six months of this year have grown 53%, but the company is still struggling with lower margins due to one-time costs to onboard new large customers. In April, the company uplisted to the Nasdaq and was added to the Russell 2000 index in the most recent reconstitution, this has seemingly led to increased volume and momentum in the stock price. With the stock, at one point, up over 100% for the year and above my estimate of fair value, I chose to exit the majority of our position at favorable prices.

BSD Analysis:
Solésence looks like a small specialty-formulation business, where value is created through IP, formulation know-how, and sticky customer relationships rather than sheer scale. These companies win when they own a high-value niche—think performance ingredients or advanced formulations where customers pay for outcomes, not commodities. The risk is that small operators can get squeezed by input-cost volatility and customer concentration. The upside is meaningful if the company is moving up the value chain into higher-margin, proprietary products with repeat demand. Investors should focus on gross margin trend, repeat customer concentration, and evidence of pricing power. If management can keep working capital tight and expand higher-margin offerings, operating leverage can appear quickly. This is a “small base, big operating leverage” setup—if it’s real.

Pitch Summary:
ImmuCell’s thesis remains intact following record first quarter results. The highlight of the quarter was the expansion in gross margins to 42%, resulting in record net income and cash flow. Management is targeting further expansion of gross margins to 45% and it appears this is within sight as there hasn’t been a contamination issue since last April and production has been operating at full capacity for two quarters in a row now. With production stabilized, the sales team is now able to pivot to bringing in new business from both existing products and the expansion into the new bulk powder First Defense product line. This new scours product will be targeted at large calf raising ranches that don’t individually dose calves for scours prevention, introducing a new market that the company historically has not served. On the mastitis side of the business, Re-Tain’s FDA license is still in limbo pending a facility inspection approval at their contract manufacturer. Although the continued delay is frustrating, the company has received authorization for investigational use of Re-Tain. This will allow ImmuCell to market the product for use and receive valuable customer feedback and data. Results of this investigational use should be available around year-end, providing valuable information to bring on a potential strategic partner for a full-scale commercial launch. I believe that ImmuCell is at a major inflection point, with scours production finally stabilized and the impending FDA approval of Re-Tain, there is a prime opportunity for any talented executive to take over the reigns with a clear path to create immense value for themselves and shareholders in the immediate future. Clearly, I am still very optimistic about the upside for ICCC as it currently is valued at a single digit multiple of earnings with near term optionality to unlock significant value through the eventual FDA approval of Re-Tain and continued growth of First Defense.

BSD Analysis:
ImmuCell is a small-cap animal health name where the core question is whether it can consistently deliver differentiated products with regulatory and manufacturing reliability. Animal health can be attractive because demand is tied to livestock economics and herd health management, not consumer gadgets. The upside is meaningful if the company has products that improve productivity or reduce disease costs for farmers—ROI sells in agriculture. The risk is that small-cap life sciences operations are vulnerable to manufacturing disruptions, regulatory delays, and lumpy order patterns. Investors should watch cash burn, product availability, and whether distribution partnerships are expanding rather than stalling. If execution stabilizes, the stock can surprise because expectations are often low for micro-cap bioscience names. This is a “prove it every quarter” story more than a narrative stock.

Pitch Summary:
ISSC was the largest contributor to our half-year performance. Record results for their fiscal second quarter released in May have propelled the stock significantly higher year to date. I believe the quarter proved what the company is capable of as they continue to expand their business through strategic acquisitions. Revenue increased 104%, gross margins improved sequentially to 51.4%, and most importantly Ebitda margins reached a high of 35% showing the benefits of operating leverage. ISSC’s acquisition strategy has been successful to date and has a large runway for continued growth from their ability to bring products in house and fully manufacturing them at their facility in Pennsylvania to increase product margins and company operating leverage. This strategy has continued runway due to their recent facility expansion which has increased capacity by more than threefold. To further this acquisition strategy, the company just recently announced a new $100 million credit facility. Although I'm optimistic about the company's future, I've decided to take advantage of the momentum and volume in the stock to reduce our position significantly prior to the release of their fiscal third quarter results to add to our cash reserves. The current share price offers a smaller margin of safety compared to when shares traded near our average purchase price of $6.50 per share.

BSD Analysis:
ISSC is a niche aerospace electronics supplier, which means the investment outcome is mostly dictated by program wins, certification cycles, and production ramps. Once avionics or cockpit systems are designed into an aircraft platform, revenue can become long-lived and sticky, but the path to that stickiness is slow and lumpy. The upside comes from expanding content on existing platforms and winning new OEM or retrofit opportunities as fleets modernize. The downside is customer concentration and the reality that small suppliers get squeezed on pricing and lead times. Investors should focus on backlog quality, gross margin stability, and evidence of repeatable program wins. This is a micro-cap aerospace supplier—high torque when things go right, thin margin for error when they don’t. If execution stays clean, the market can rerate it from “tiny supplier” to “durable niche franchise.”